K. Fassbender et al., MOOD DISORDERS AND DYSFUNCTION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN MULTIPLE-SCLEROSIS - ASSOCIATION WITH CEREBRAL INFLAMMATION, Archives of neurology, 55(1), 1998, pp. 66-72
Objective: To investigate the association between affective and neuroe
ndocrine abnormalities, commonly observed in multiple sclerosis, with
inflammatory disease activity. Design: Cross-sectional design. Twenty-
three patients with definite relapsing-remitting multiple sclerosis an
d age-and sex-matched control subjects were investigated. Depression a
nd anxiety were assessed using structured interviews, self-report meas
ures, and Diagnostic and Statistical Manual of Mental Disorders, Third
Edition, Revised criteria. Neurologic impairment was assessed by the
Kurtzke Expanded Disability Status Scale and function of hypothalamic-
adrenal-pituitary axis was analyzed using a corticotropin-releasing ho
rmone stimulation test after dexamethasone suppression. Inflammatory d
isease activity was evaluated first by routine and experimental labora
tory tests, and second by magnetic resonance assessment of gadolinium
uptake of multiple sclerotic plaques. Setting: University hospital, a
major provider of acute neurologic care. Results: Compared with contro
ls, patients with multiple sclerosis had higher scores on depression a
nd anxiety scales and exhibited a failure of suppression of cortisol r
elease after dexamethasone pretreatment. Both affective symptoms and n
euroendocrine abnormalities were correlated with cerebrospinal fluid w
hite blood cell counts and presence of gadolinium-enhancing lesions on
magnetic resonance images; however, no association with the degree of
neurologic impairment was observed. Conclusion: Affective and neuroen
docrine disorders were related to inflammatory disease activity but no
t to degree of disability, supporting the hypothesis that these sympto
ms are causally associated with brain injury.